Procter & Gamble Co. (PG): A strong start to the year with a top- & bottom-line beat in FQ1, but FY27 guidance maintained on higher cost pressures

Heading into PG's FQ1 earnings, investor sentiment had improved as scanner data indicated sequential acceleration in consumption trends, though concerns remained around elevated gas prices and macro volatility. PG's strong FQ1 results still exceeded incoming expectations and likely drove the stock reaction (+6% vs. SPX ~2.7%). PG reported a sizable EPS beat at $2.00 (vs. GS/FactSet consensus $1.87) on organic sales growth of +4.0% (vs. GS/Visible Alpha consensus +2.3%/+2.2%), in-line gross margins (partly aided by $90mn tariff refunds offsetting rising commodity costs), and lower SG&A, resulting in operating margins of 25.9% (vs. GS/consensus 24.7%/24.9%). Management largely reiterated FY27 organic sales growth and core EPS guidance but guided to meaningfully higher cost pressure for the fiscal year, consistent with our expectations. Rising input cost inflation will likely pressure staples companies more broadly, and we believe incremental pricing actions may be necessary across the in